Abacaviri sulfas, Lamivudinum, Zidovudinum

Medicinal product name Trizivir
Pharmaceutical form Film-coated tablet
Strength 300 mg/150 mg/300 mg 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Risk minimisation measuresIzglītojošie materiāli pacientam Izglītojošie materiāli pacientam
ATC code J05AR04 Antivirals for systemic use

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N60
(1 UD)
PVC/PCTFE/PVC/AL blister    EU/1/00/156/004  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/00/156/004
Date of authorisation May 12, 2010
Marketing authorisation holder, country Viiv Healthcare B.V., Netherlands